These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38423415)

  • 1. Impact of a positive crossmatch on pediatric heart transplant outcomes.
    Milligan C; Williams RJ; Singh TP; Bastardi HJ; Esteso P; Almond CS; Gauvreau K; Daly KP
    J Heart Lung Transplant; 2024 Jun; 43(6):963-972. PubMed ID: 38423415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac transplant outcomes in pediatric patients with pre-formed anti-human leukocyte antigen antibodies and/or positive retrospective crossmatch.
    Wright EJ; Fiser WP; Edens RE; Frazier EA; Morrow WR; Imamura M; Jaquiss RD
    J Heart Lung Transplant; 2007 Nov; 26(11):1163-9. PubMed ID: 18022083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcomes of eculizumab-treated positive crossmatch recipients: Allograft survival, histologic findings, and natural history of the donor-specific antibodies.
    Schinstock CA; Bentall AJ; Smith BH; Cornell LD; Everly M; Gandhi MJ; Stegall MD
    Am J Transplant; 2019 Jun; 19(6):1671-1683. PubMed ID: 30412654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent strong anti-HLA antibody at high titer is complement binding and associated with increased risk of antibody-mediated rejection in heart transplant recipients.
    Zeevi A; Lunz J; Feingold B; Shullo M; Bermudez C; Teuteberg J; Webber S
    J Heart Lung Transplant; 2013 Jan; 32(1):98-105. PubMed ID: 23142561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correlation of Luminex-Based Single Antigen Based Results With Complement-Dependent Cytotoxicity Crossmatch and Flow Cytometry Crossmatch Results: A Single-Center Experience From Istanbul.
    Oguz SR; Sinangil A; Barlas S; Ciftci HS; Ulusoy E; İzgi DK; Ogret Y; Ecder T; Akin B
    Transplant Proc; 2023 Mar; 55(2):303-308. PubMed ID: 36890054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement-dependent cytotoxicity crossmatch in solid organ transplantation: The gold standard or golden history?
    Tafulo S; Osório E; Mendes C; Liwski R
    Hum Immunol; 2024 Jan; 85(1):110734. PubMed ID: 38030522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative analysis of complement-dependent lymphocytotoxicity crossmatch and flow cytometry crossmatch results versus Luminex single-antigen bead-based donor-specific IgG class I antibody MFI values in live related renal transplant cases; a retrospective observation in 102 cases.
    Pandey P; Pande A; Kumar Devra A; Kumar Sinha V; Prasad Bhatt A
    J Immunoassay Immunochem; 2021 May; 42(3):300-313. PubMed ID: 33356865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined liver-kidney transplantation with positive crossmatch: Role of delayed kidney transplantation.
    Goggins WC; Ekser B; Rokop Z; Lutz AJ; Mihaylov P; Mangus RS; Fridell JA; Powelson JA; Kubal CA
    Surgery; 2021 Oct; 170(4):1240-1247. PubMed ID: 34092375
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Virtual crossmatch in kidney transplantation.
    Piazza A; Ozzella G; Poggi E; Caputo D; Manfreda A; Adorno D
    Transplant Proc; 2014 Sep; 46(7):2195-8. PubMed ID: 25242749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric heart transplantation across a positive crossmatch: First year results from the CTOTC-04 multi-institutional study.
    Webber S; Zeevi A; Mason K; Addonizio L; Blume E; Dipchand A; Shaddy R; Feingold B; Canter C; Hsu D; Mahle W; Armstrong B; Morrison Y; Ikle D; Diop H; Odim J;
    Am J Transplant; 2018 Sep; 18(9):2148-2162. PubMed ID: 29673058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Donor-specific HLA alloantibodies: Impact on cardiac allograft vasculopathy, rejection, and survival after pediatric heart transplantation.
    Tran A; Fixler D; Huang R; Meza T; Lacelle C; Das BB
    J Heart Lung Transplant; 2016 Jan; 35(1):87-91. PubMed ID: 26422083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel Flow Cytometry-Based Method for Detection of Anti-HLA Complement Activating Donor-Specific Antibodies in Renal Transplant Recipients and Its Comparison With Other Conventional Detection Methods.
    Rani L; Singh H; Saikia B; Aggarwal R; Kumar Y; Kumar M; Chhabra S; Kumar M; Kumar B; Kumar V; Das P; Sharma A; Ramchandran R; Kohli HS; Minz RW
    Transplant Proc; 2023; 55(1):134-139. PubMed ID: 36609023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk stratification by the virtual crossmatch: a prospective study in 233 renal transplantations.
    Amico P; Hirt-Minkowski P; Hönger G; Gürke L; Mihatsch MJ; Steiger J; Hopfer H; Schaub S
    Transpl Int; 2011 Jun; 24(6):560-9. PubMed ID: 21332582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of alloantibody strength in crossmatch negative DSA positive kidney transplantation.
    Wu P; Jin J; Everly MJ; Lin C; Terasaki PI; Chen J
    Clin Biochem; 2013 Oct; 46(15):1389-93. PubMed ID: 23726814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kidney Transplant With Low Levels of DSA or Low Positive B-Flow Crossmatch: An Underappreciated Option for Highly Sensitized Transplant Candidates.
    Schinstock CA; Gandhi M; Cheungpasitporn W; Mitema D; Prieto M; Dean P; Cornell L; Cosio F; Stegall M
    Transplantation; 2017 Oct; 101(10):2429-2439. PubMed ID: 28009780
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of human leukocyte antigen-C and -DQ matching on pediatric heart transplant graft survival.
    Butts RJ; Savage AJ; Nietert PJ; Kavarana M; Moussa O; Burnette AL; Atz AM
    J Heart Lung Transplant; 2014 Dec; 33(12):1282-7. PubMed ID: 25128416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of a positive flow crossmatch on the outcomes of cadaveric renal transplants.
    Ilham MA; Winkler S; Coates E; Rizzello A; Rees TJ; Asderakis A
    Transplant Proc; 2008; 40(6):1839-43. PubMed ID: 18675065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemporary outcomes of pediatric cardiac transplantation with a positive retrospective crossmatch.
    Lytrivi ID; Koehl D; Esteso P; Frandsen EL; Gibbons MK; Kirklin JK; Cantor R; Lamour JM; Putschoegl A; Shugh S; Williams RJ; Pearce FB
    Pediatr Transplant; 2023 Nov; 27(7):e14593. PubMed ID: 37602972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mortality and morbidity in pre-sensitized pediatric heart transplant recipients with a positive donor crossmatch utilizing peri-operative plasmapheresis and cytolytic therapy.
    Holt DB; Lublin DM; Phelan DL; Boslaugh SE; Gandhi SK; Huddleston CB; Saffitz JE; Canter CE
    J Heart Lung Transplant; 2007 Sep; 26(9):876-82. PubMed ID: 17845925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.